Terns Pharmaceuticals Inc (TERN)
5.905
-0.24
(-3.83%)
USD |
NASDAQ |
May 17, 16:00
5.905
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Total Assets (Quarterly): 246.77M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 246.77M |
December 31, 2023 | 268.52M |
September 30, 2023 | 271.69M |
June 30, 2023 | 289.70M |
March 31, 2023 | 301.28M |
December 31, 2022 | 287.03M |
September 30, 2022 | 192.59M |
June 30, 2022 | 144.86M |
Date | Value |
---|---|
March 31, 2022 | 156.67M |
December 31, 2021 | 168.07M |
September 30, 2021 | 179.89M |
June 30, 2021 | 188.01M |
March 31, 2021 | 199.24M |
December 31, 2020 | 92.29M |
September 30, 2020 | 17.41M |
December 31, 2019 | 23.90M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
17.41M
Minimum
Sep 2020
301.28M
Maximum
Mar 2023
189.24M
Average
190.30M
Median
Total Assets (Quarterly) Benchmarks
Viking Therapeutics Inc | 967.52M |
Eli Lilly and Co | 63.94B |
Pfizer Inc | 221.10B |
Amgen Inc | 92.98B |
Madrigal Pharmaceuticals Inc | 1.082B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 10.05M |
Shareholders Equity (Quarterly) | 236.72M |